Education: Bachelor's of Science in Natural Science; Nuclear Medicine Technology, Worcester State College
Years of Experience: 11+ years
Location: New Haven, CT
Education: Ph.D. in Medical Physics, University of Uppsala
Years of Experience: 34+ years
Location: Boston, MA
Dr. Karen Briley has worked in pre-clinical translational imaging for over 30 years. Indication areas include cardiovascular, gastrointestinal, NASH, and other inflammatory diseases.
Education: Ph.D. in Chemistry, The University of Hull
Years of Experience: 8+ years
Location: London, UK
Education: Master’s Degree in Forensic Science, King’s College London
Bachelor’s Degree in Physiology, Trinity College
Years of Experience: 15+ years
Location: London, UK
Ms. Ciara Finucane joined Invicro in January 2013 and specializes in nuclear techniques, including the evaluation of molecular targets for radionuclide-mediated diagnosis and therapy of cancer. With over 15 years of experience, her area of expertise is in preclinical SPECT and PET imaging and includes work with academia and pharmaceutical industry in the design, execution, and project management of nuclear imaging studies.
Ms. Finucane received her honors degree in Natural Sciences, in Physiology from Trinity College, Dublin and her Master of Science in Forensic Sciences from Kings College London. Prior to Invicro, Ms. Finucane was at the Bart’s Cancer Institute at Queen Mary University of London in the Center for Molecular Imaging to develop cancer therapeutic and imaging agents.
Education: Ph.D. in Engineering, University of Warwick
Years of Experience: 30+ years
Location: London, UK
Dr. Roger Gunn is an international expert in PET neuroimaging with 30 years of experience designing and analyzing imaging studies for disease understanding and drug development. Dr. Gunn is also a Professor of Molecular Neuroimaging at Imperial College London and has published over 200 peer-reviewed papers in the field of imaging with an H-Index of 65.
Education: Ph.D. in Chemistry, Syracuse University
Years of Experience: 10+ years
Location: Boston, MA
Education: Master’s Degree in Electrical Engineering, Tufts University
Years of Experience: 28+ years
Location: Boston, MA
Mr. Ed Hogan has over 28 years of experience in clinical research, managing and executing phase I-IV imaging trials in both the pharmaceutical and CRO space. He brings more than 19 years of experience in managing clinical operations, including extensive experience in building and leading global cross-functional operations teams, including project, image, data and reader management.
Education: Ph.D., Mechanical Engineering (biomedical applications), Boston University
Years of Experience: 8+ years
Location: Boston, MA
Dr. Amira Hussein works with our sponsors and internal teams to design and execute pre-clinical imaging studies in various therapeutic areas including oncology, musculoskeletal and systemic diseases.
Education: M.Sc. in Pharmacology, Michigan State University
Years of Experience: 16+ years
Location: Boston, MA
Mr. Dustin Kentala has been working in the CRO industry for 16 years with 11 years as an imaging scientist, study director, or above specializing in in vivo imaging techniques such as: PET, SPECT and CT. In addition, his graduate research focused on ocular drug delivery and pharmacology with specific experience evaluating AAV-mediated gene delivery for inherited retinal diseases.
Education: Cancer Biology, Wayne State University
Years of Experience: 20+ years
Location: Boston, MA
Dr. Joseph Krueger's experience in oncology drug discovery and development in two different pharma companies lead to his love for pathology endpoints and interest in artificial intelligence-based image analysis of tissues, and his desire to start a company in the field. Dr. Krueger's depth of experience in pathology IA-AI was advanced by the challenges in immuno-oncology biomarker strategies during his role as CSO of Flagship Biosciences. Dr. Krueger continues to help build advances in the field for a variety of drug discovery and development areas as part of the multidisciplinary team at Invicro.
Education: M.D.,Ph.D. University of Virginia
AB Chemistry, Harvard University
Years of Experience: 15+ years
Location: Boston, MA
Dr. Kuo was a tenured Professor in the Departments of Medical Imaging, Medicine and Biomedical Engineering at the University of Arizona. Beyond his academic work, Dr. Kuo has vast experience as a consultant, reader and speaker for CROs and pharmaceutical companies.
Dr. Kuo has authored over 100 publications and has received numerous grants covering a diverse range of disciplines. Dr. Kuo received his A.B. from Harvard University, M.D. and Ph.D. from the University of Virginia, completed his Internal Medicine Residency at UCLA Medical Center, and Diagnostic Radiology Residency and Nuclear Medicine Fellowship at Yale New Haven Hospital.
At Invicro, Dr. Kuo supports the design, performance and analysis of clinical trials and also supports regulatory approval and post-approval activities such as reader training.
Education: Ph.D. in Physical Chemistry, Freie Universität Berlin
Years of Experience: 15+ years
Location: London, UK
Dr. Sven Macholl studied Chemistry in Kiel, Germany while in parallel, worked in the marine chemistry lab of the local institute of marine sciences. Dr. Macholl specialized in physical chemistry/chemical physics for his diploma thesis performing microwave spectroscopy of small molecules using quantum mechanics for analysis. Dr. Macholl spent time in academia in Berlin, Magdeburg and St. Petersburg, Russia in the related fields of NMR spectroscopy, clinical MRS & fMRI and experimental low field MRI. Dr. Macholl later joined GE Healthcare in the UK to perform research in the novel Dissolution Dynamic Nuclear Polarization technique with one of its inventors. Having spent time alongside medicinal chemists and the radio nuclear imaging scientists at the site, he then decided to join the radio nuclear R&D team as a physicist/image analyst and preclinical lab scientist working with rodents.
Dr. Macholl joined Invicro in 2014 performing and managing preclinical imaging projects across all major imaging modalities. Currently, he manages the contract research performed at academic preclinical partner labs, as well as working with the neuro-imaging team in the UK and supporting the various preclinical and translational U.S. teams.
Education: M.D., Superior School of Health Sciences and University of Porto
Ph.D., University of Utrecht
Years of Experience: 8 years
Location: Boston, MA
Dr. Montgomery holds two medical degrees, one from the Superior School of Health Sciences, Brazil and another from the University of Porto, Portugal. She completed her residency in Radiology and earned a Ph.D. from the University of Utrecht (Netherlands) in breast cancer imaging.
Dr. Montgomery has seven years of national and international experience in breast cancer imaging clinical trials phases I-IV, and published several scientific peer-reviewed manuscripts in journals, such as Radiology and European Radiology, as first author. She has expertise in protocol design, statistical analysis, imaging evaluation, regulatory affairs, artificial intelligence and business development.
Education: Ph.D. in Biomedical Engineering, Yale University
Years of Experience: 3+ years
Location: New Haven, CT
Education: Associates of Applied Science, Nuclear Medicine Technology, Gateway Community Technical College
Years of Experience: 25+ years
Location: New Haven, CT
Education: Ph.D. in Chemistry, University of Missouri
Years of Experience: 7+ years
Location: Boston, MA
Education: Ph.D. in Nuclear Engineering, University of Michigan
Years of Experience: 31+ years
Location: Boston, MA
Dr. Ken Zasadny has a mix of academia and pharmaceutical industry experience. His career focus has been on quantitative molecular imaging by PET and SPECT for diagnostic and therapeutic applications.
.jpg?width=1384&name=Carlin_101129_28_Adj2%20(2).jpg)
.png?width=300&name=bwheadshot%20(1).png)